-
Andre, T., Vernerey, D., Im, S. A., Bodoky, G., Buzzoni, R., Reingold, S., Tabernero, J., et al. (2020). Bevacizumab as adjuvant treatment of colon cancer: Updated results from the S-AVANT phase III study by the GERCOR group. Annals of Oncology, 31(2), 246-256. doi: 10.1016/j.annonc.2019.12.006
Bevacizumab as adjuvant treatment of colon cancer: Updated results from the S-AVANT phase III study by the GERCOR group
on 16 de març de 2020
with No hi ha comentaris
Deixa un comentari